Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 6 studies | 31% ± 19% | |
| endothelial cell of lymphatic vessel | 5 studies | 21% ± 5% | |
| smooth muscle cell | 4 studies | 28% ± 10% | |
| endothelial cell | 3 studies | 19% ± 4% | |
| fibroblast | 3 studies | 30% ± 11% | |
| glial cell | 3 studies | 28% ± 9% |
Insufficient scRNA-seq data for expression of OLFML2A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 6118.89 | 653 / 653 | 95% | 58.31 | 574 / 605 |
| esophagus | 99% | 3892.16 | 1427 / 1445 | 96% | 37.80 | 175 / 183 |
| breast | 98% | 3513.19 | 452 / 459 | 94% | 24.53 | 1054 / 1118 |
| uterus | 99% | 7584.47 | 168 / 170 | 83% | 29.40 | 381 / 459 |
| bladder | 100% | 4958.86 | 21 / 21 | 75% | 17.38 | 380 / 504 |
| lung | 94% | 3071.19 | 543 / 578 | 80% | 17.64 | 919 / 1155 |
| ovary | 97% | 3437.39 | 175 / 180 | 67% | 15.21 | 290 / 430 |
| skin | 91% | 3059.15 | 1654 / 1809 | 68% | 19.41 | 321 / 472 |
| intestine | 92% | 5723.47 | 893 / 966 | 66% | 9.96 | 346 / 527 |
| prostate | 95% | 2273.41 | 233 / 245 | 60% | 7.61 | 299 / 502 |
| kidney | 81% | 992.51 | 72 / 89 | 71% | 52.39 | 642 / 901 |
| stomach | 63% | 1188.08 | 226 / 359 | 76% | 12.05 | 218 / 286 |
| pancreas | 43% | 444.91 | 142 / 328 | 91% | 17.10 | 162 / 178 |
| adrenal gland | 44% | 566.35 | 113 / 258 | 71% | 26.50 | 164 / 230 |
| spleen | 100% | 7739.29 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 23.17 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 27.97 | 44 / 45 |
| heart | 96% | 2715.05 | 825 / 861 | 0% | 0 | 0 / 0 |
| adipose | 94% | 3503.22 | 1135 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 73% | 1774.45 | 589 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 57% | 1107.46 | 766 / 1335 | 0% | 0 | 0 / 0 |
| brain | 5% | 51.46 | 123 / 2642 | 40% | 6.31 | 279 / 705 |
| eye | 0% | 0 | 0 / 0 | 36% | 4.56 | 29 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 31% | 4.52 | 9 / 29 |
| liver | 1% | 8.58 | 2 / 226 | 29% | 3.55 | 118 / 406 |
| peripheral blood | 1% | 6.00 | 5 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_0005615 | Cellular component | extracellular space |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0050840 | Molecular function | extracellular matrix binding |
| GO_0042802 | Molecular function | identical protein binding |
| Gene name | OLFML2A |
| Protein name | Olfactomedin-like protein 2A (Photomedin-1) Olfactomedin like 2A |
| Synonyms | UNQ9394/PRO34319 |
| Description | |
| Accessions | Q68BL7 ENST00000288815.5 [Q68BL7-3] ENST00000373580.8 [Q68BL7-1] Q5JTM7 ENST00000331715.13 |
